Peddireddy, A.S.; Huey, R.; Wolff, R.A.; Lin, K.; Mitchell, J.; Scofield, L.; Jacob, S.; Nguyen, D.V.; Rogers, J.; Portier, S.;
et al. Clinicopathologic Features Associated with Survival for Immune Checkpoint Blockade in Patients with Metastatic Anal Cancer. Cancers 2025, 17, 937.
https://doi.org/10.3390/cancers17060937
AMA Style
Peddireddy AS, Huey R, Wolff RA, Lin K, Mitchell J, Scofield L, Jacob S, Nguyen DV, Rogers J, Portier S,
et al. Clinicopathologic Features Associated with Survival for Immune Checkpoint Blockade in Patients with Metastatic Anal Cancer. Cancers. 2025; 17(6):937.
https://doi.org/10.3390/cancers17060937
Chicago/Turabian Style
Peddireddy, Arjun S., Ryan Huey, Robert A. Wolff, Kangyu Lin, Jocelyn Mitchell, Lisa Scofield, Sophia Jacob, Diem V. Nguyen, Jane Rogers, Shaelynn Portier,
and et al. 2025. "Clinicopathologic Features Associated with Survival for Immune Checkpoint Blockade in Patients with Metastatic Anal Cancer" Cancers 17, no. 6: 937.
https://doi.org/10.3390/cancers17060937
APA Style
Peddireddy, A. S., Huey, R., Wolff, R. A., Lin, K., Mitchell, J., Scofield, L., Jacob, S., Nguyen, D. V., Rogers, J., Portier, S., Foo, W. C., Eng, C., & Morris, V. K.
(2025). Clinicopathologic Features Associated with Survival for Immune Checkpoint Blockade in Patients with Metastatic Anal Cancer. Cancers, 17(6), 937.
https://doi.org/10.3390/cancers17060937
